Novartis India Limited, a active public limited company, was established on 13 December 1947 in Bandra, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: L24200MH1947PLC006104. Registered under ROC Roc Mumbai. it is listed on BSE: 500672 and NSE: NOVARTIND. It has an authorized capital of ₹32.00 Cr and a paid-up capital of ₹12.35 Cr.
Formerly known as Ciba (India) Private Limited, Ciba (India) Limited. It upholds a compliant status. In 2023, it reported revenue of ₹436.85 Cr and a net worth of ₹775.66 Cr. Employing 59 professional, Its leadership includes Shilpa Shashank Joshi (Cfo), Sandra Martyres (Director), Gira Jagdeesh Sardesai (Director). Past directors included Erwin Schillinger, Girish Arjan Tekchandani, Monaz Noble. It holds no open charges and ₹257.48 Cr settled loans. Its latest AGM occurred on 31 July 2025, with the balance sheet filed on 31 March 2025. It is based at Inspire Bkc 7Th Floor Bandra Kurla Complex, Bandra East, Bandra, Maharashtra, 400051.
L24200MH1947PLC006104
006104
13 December 1947
₹32.00 Cr
₹12.35 Cr
Roc Mumbai
Listed (BSE: 500672, NSE: NOVARTIND)
Active
Explore comprehensive insights into Novartis India Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shilpa Shashank Joshi | Cfo | 01 May 2022 | Current |
| Sandra Martyres | Director | 19 Apr 2016 | Current |
| Gira Jagdeesh Sardesai | Director | 31 Mar 2024 | Current |
| Christopher David Snook | Director | 01 Aug 2008 | Current |
| Falin Ishwarlal Majmudar | Whole-Time Director | 28 Jun 2024 | Current |
| Sanker Parameswaran | Director | 22 Jun 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Oct 2007 | Past |
| Pramod Abcsdd | Company Secretary | 12 Aug 2016 | Past |
| Pramod Abcsdd | Director | 22 Nov 2022 | Past |
| Pramod Abcsdd | Cfo(Kmp) | - | Past |
| Pramod Abcsdd | Director | 31 Mar 2020 | Past |
| Pramod Abcsdd | Company Secretary | 30 Apr 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novartis India Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.88% increase. The company also saw a substantial improvement in profitability, with a 2878.49% increase in profit. The company's net worth Soared by an impressive increase of 12.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Novartis India had a promoter holding of 70.68% and a public holding of 29.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,574,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 1999 | Bnp Paribas | ₹33.00 Cr | Satisfied |
| 02 May 1998 | The Hongkong And Shanghai Banking Corporation Ltd. | ₹5.00 Cr | Satisfied |
| 21 Jul 1993 | Allahabad Bank | ₹45.00 Cr | Satisfied |
| 21 Jul 1993 | Grindlays Bank | ₹45.00 Cr | Satisfied |
| 28 May 1992 | Grindlays Bank | ₹38.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Novartis India has a workforce of 59 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Novartis India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novartis India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Novartis India Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records. was completed.
The activity Novartis India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
A charge registered on 06 Aug 1940 via Charge ID 90230132 with The National Bank Of India Ltd. was fully satisfied on 20 Aug 2024. was recorded as a recent event.
Progress on A charge registered on 21 Jul 1993 via Charge ID 90228667 with Grindlays Bank was fully satisfied on 01 Jul 2024. was documented.
Progress on A charge registered on 17 Aug 1982 via Charge ID 90227632 with Grindlays Bank was fully satisfied on 01 Jul 2024. was documented.
The activity Falin Ishwarlal Majmudar was appointed as a Whole-time director was appointed as a Whole-time director on 28 Jun 2024 & has been associated with this company since 1 year 4 months . was completed.
This partnership will enable Cipla arm (Breathe Free Lanka) to facilitate easy access to Ultibro Breezhaler for patients in Sri Lanka to help them alleviate specific debilitating symptoms of... .
The CIN of Novartis India Limited is L24200MH1947PLC006104.
Novartis India Limited is headquartered at Inspire Bkc 7Th Floor Bandra Kurla Complex, Bandra East, Bandra, Maharashtra, 400051.
Novartis India Limited was incorporated on 13 December 1947.
The current directors of Novartis India Limited are
The primary industry of Novartis India Limited is Trade.
Novartis India Limited is listed. It is listed on BSE: 500672 and NSE: NOVARTIND.
The authorized capital of Novartis India Limited is ₹32.00 Cr, and the paid-up capital is ₹12.35 Cr.
The compliance status of Novartis India Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX